The breast cancer cells when incubated with pentapeptide (1000 μg/mL) exhibited a significant down regulation of ‘Cyclooxygenase-2 [COX-2]’ (target for breast cancer treatment) in MCF-7 cells at 96 h. This evidence concerns the gene PTGS2 and breast carcinoma.